N-Acetylglucosamine mitigates lung injury and pulmonary fibrosis induced by bleomycin

N-Acetylglucosamine mitigates lung injury and pulmonary fibrosis induced by bleomycin

Lung injury and pulmonary fibrosis contribute to morbidity and mortality, and, in particular, are characterized as leading cause on confirmed COVID-19 death. To date, efficient therapeutic approach for such lung diseases is lacking. N-Acetylglucosamine (NAG), an acetylated derivative of glucosamine,...

Full description

Bibliographic Details
Main Authors: Jinyu Li, Xiaohui Xu, Jiane Liu, Yunqing Chen, Shengxi Jin, Guangmin Zhang, Shulan Yin, Jingqi Wang, Kangqi Tian, Xiaoyang Luan, Xiaohua Tan, Xiangzhong Zhao, Na Zhang, Zheng Wang
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
N-Acetylglucosamine
Bleomycin
Macrophages
Lung injury
Pulmonary fibrosis
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223008600

Similar Items

Similar Items